| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.07 |